135 related articles for article (PubMed ID: 31719634)
1. Sangivamycin and its derivatives inhibit Haspin-Histone H3-survivin signaling and induce pancreatic cancer cell death.
Bastea LI; Hollant LMA; Döppler HR; Reid EM; Storz P
Sci Rep; 2019 Nov; 9(1):16588. PubMed ID: 31719634
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the chromatin phosphoproteome by the Haspin protein kinase.
Maiolica A; de Medina-Redondo M; Schoof EM; Chaikuad A; Villa F; Gatti M; Jeganathan S; Lou HJ; Novy K; Hauri S; Toprak UH; Herzog F; Meraldi P; Penengo L; Turk BE; Knapp S; Linding R; Aebersold R
Mol Cell Proteomics; 2014 Jul; 13(7):1724-40. PubMed ID: 24732914
[TBL] [Abstract][Full Text] [Related]
3. 3H-pyrazolo[4,3-f]quinoline haspin kinase inhibitors and anticancer properties.
Opoku-Temeng C; Dayal N; Aflaki Sooreshjani M; Sintim HO
Bioorg Chem; 2018 Aug; 78():418-426. PubMed ID: 29698892
[TBL] [Abstract][Full Text] [Related]
4. HASPIN is involved in the progression of gallbladder carcinoma.
Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin.
Huertas D; Soler M; Moreto J; Villanueva A; Martinez A; Vidal A; Charlton M; Moffat D; Patel S; McDermott J; Owen J; Brotherton D; Krige D; Cuthill S; Esteller M
Oncogene; 2012 Mar; 31(11):1408-18. PubMed ID: 21804608
[TBL] [Abstract][Full Text] [Related]
6. VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis.
Moura DS; Campillo-Marcos I; Vázquez-Cedeira M; Lazo PA
Cell Mol Life Sci; 2018 Jul; 75(14):2591-2611. PubMed ID: 29340707
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines.
Nishida-Fukuda H; Tokuhiro K; Ando Y; Matsushita H; Wada M; Tanaka H
PLoS One; 2021; 16(4):e0249912. PubMed ID: 33852630
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity.
Melms JC; Vallabhaneni S; Mills CE; Yapp C; Chen JY; Morelli E; Waszyk P; Kumar S; Deming D; Moret N; Rodriguez S; Subramanian K; Rogava M; Cartwright ANR; Luoma A; Mei S; Brinker TJ; Miller DM; Spektor A; Schadendorf D; Riggi N; Wucherpfennig KW; Sorger PK; Izar B
Cancer Res; 2020 Feb; 80(4):798-810. PubMed ID: 31882401
[TBL] [Abstract][Full Text] [Related]
9. Coumestrol Epigenetically Suppresses Cancer Cell Proliferation: Coumestrol Is a Natural Haspin Kinase Inhibitor.
Kim JE; Lee SY; Jang M; Choi HK; Kim JH; Chen H; Lim TG; Dong Z; Lee KW
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064398
[TBL] [Abstract][Full Text] [Related]
10. ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
Stockwin LH; Yu SX; Stotler H; Hollingshead MG; Newton DL
BMC Cancer; 2009 Feb; 9():63. PubMed ID: 19232100
[TBL] [Abstract][Full Text] [Related]
11. Two histone marks establish the inner centromere and chromosome bi-orientation.
Yamagishi Y; Honda T; Tanno Y; Watanabe Y
Science; 2010 Oct; 330(6001):239-43. PubMed ID: 20929775
[TBL] [Abstract][Full Text] [Related]
12. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
13. Co-inhibition of Aurora A and Haspin kinases enhances survivin blockage and p53 induction for mitotic catastrophe and apoptosis in human colorectal cancer.
Lin CI; Chen ZC; Chen CH; Chang YH; Lee TC; Tang TT; Yu TW; Yang CM; Tsai MC; Huang CC; Yang TW; Lin CC; Wang RH; Chiou GY; Jong YJ; Chao JI
Biochem Pharmacol; 2022 Dec; 206():115289. PubMed ID: 36241092
[TBL] [Abstract][Full Text] [Related]
14. Methylation-mediated control of aurora kinase B and Haspin with epigenetically modified histone H3 N-terminal peptides.
Han A; Lee KH; Hyun S; Lee NJ; Lee SJ; Hwang H; Yu J
Bioorg Med Chem; 2011 Apr; 19(7):2373-7. PubMed ID: 21397507
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.
Gupta PK; Daunert S; Nassiri MR; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1989 Feb; 32(2):402-8. PubMed ID: 2913300
[TBL] [Abstract][Full Text] [Related]
16. Haspin inhibition delays cell cycle progression through interphase in cancer cells.
Wang P; Hua X; Bryner YH; Liu S; Gitter CB; Dai J
J Cell Physiol; 2020 May; 235(5):4508-4519. PubMed ID: 31625162
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone H1 phosphorylation by sangivamycin and other pyrrolopyrimidine analogues.
Saffer JD; Glazer RI
Mol Pharmacol; 1981 Jul; 20(1):211-7. PubMed ID: 7290086
[No Abstract] [Full Text] [Related]
18. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
19. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
[TBL] [Abstract][Full Text] [Related]
20. Chromosome segregation regulation in human zygotes: altered mitotic histone phosphorylation dynamics underlying centromeric targeting of the chromosomal passenger complex.
van de Werken C; Avo Santos M; Laven JS; Eleveld C; Fauser BC; Lens SM; Baart EB
Hum Reprod; 2015 Oct; 30(10):2275-91. PubMed ID: 26223676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
